{
  "author": {
    "name": "Benjamin Elgin",
    "webUrl": "/author/profile/benjamin-elgin/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 2,
    "social": [],
    "articles": [
      {
        "uri": "/2019/12/06/sec-chairman-cites-fishy-letters-in-support-of-policy-change-412-90845/",
        "title": "SEC chairman cites fishy letters in support of policy change",
        "byline": "Zachary R. Mider & Benjamin Elgin",
        "kicker": "News",
        "prettyDate": "December 06, 2019",
        "timeToRead": "9 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/11/SEC-Clayton-Jay-2019-034-radzinschi.jpg",
          "width": "616",
          "height": "412"
        },
        "authors": [
          {
            "webUrl": "/author/profile/zachary-r-mider/",
            "name": "Zachary R. Mider"
          },
          {
            "webUrl": "/author/profile/benjamin-elgin/",
            "name": "Benjamin Elgin"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Some \"ordinary Americans\" whose correspondence Clayton referenced said they did not write the letters, or were even unaware of the letters' existence.",
        "body": null
      },
      {
        "uri": "/2017/12/27/drug-companies-relationships-with-patient-assistan/",
        "title": "Drug companies' relationships with patient-assistance charities under scrutiny",
        "byline": " Robert Langreth, Benjamin Elgin ",
        "kicker": "",
        "prettyDate": "December 27, 2017",
        "timeToRead": "6 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/robert-langreth-benjamin-elgin/",
            "name": "Robert Langreth, Benjamin Elgin"
          }
        ],
        "kickerNode": [],
        "summary": "For the past two years federal regulators have issued subpoenas and scrutinized relationships between drug companies and the charities, which are supposed to operate independently from industry donors.",
        "body": null
      }
    ]
  }
}